Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	108.60	3.82	1.83
Graham Fair Price	-39.03	30.43	49.91
PEG	421.65	-0.04	< 0.005
Price/Book	-15.91	0.18	0.21
Price/Cash Flow	-77.56	-4.88	21.75
Prices/Earnings	134.74	5.75	-2.45
Price/Sales	-2.03	0.26	0.27
Price/FCF	-77.56	-4.88	21.75
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-17.13	0.14	0.17
Operating Margin	180.65	-0.02	< 0.005
ROA	-62.36	< 0.005	< 0.005
ROE	-0.02	< 0.005	-64.18
ROIC	< 0.005	-0.02	-533.03
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.12	0.55	-78.89
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.75	-3.45	-362.45
EPS QOQ	-3.04	1.37	-55.00
FCF QOQ	0.01	-4.82	44384.88
Revenue QOQ	0.04	-0.13	251.44
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	41.61	46.09	10.78
Days Sales Outstanding (DSO)	70.38	72.43	2.91
Inventory Turnover	2.16	1.95	-9.73
Debt/Capitalization	0.16	0.22	35.08
Quick Ratio	0.90	0.85	-6.06
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	71.24	72.58	1.87
Cash	26.58	28.05	5.54
Capex	-5.64	-3.74	33.69
Free Cash Flow	0.70	-2.67	281.79
Revenue	56.92	49.77	-12.56
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.21	1.21	-0.38
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.27	-2.97	-31.00
Naive Interpretation	Member

06 - Financial Health · Weak

Rating